Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
5819 | 1571 | 28.5 | 73% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
141 | 3 | TUBERCULOSIS//INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE//MYCOBACTERIUM TUBERCULOSIS | 64640 |
373 | 2 | MYCOBACTERIUM TUBERCULOSIS//TUBERCULOSIS//INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES | 17241 |
5819 | 1 | MYCOBACTERIUM AVIUM//RIFABUTIN//MYCOBACTERIUM AVIUM COMPLEX | 1571 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MYCOBACTERIUM AVIUM | authKW | 256329 | 5% | 18% | 74 |
2 | RIFABUTIN | authKW | 198474 | 3% | 24% | 43 |
3 | MYCOBACTERIUM AVIUM COMPLEX | authKW | 179805 | 4% | 16% | 57 |
4 | MICROBIOL IMMUNOL INFECT | address | 140299 | 1% | 38% | 19 |
5 | KUZELL ARTHRIT INFECT DIS | address | 138188 | 1% | 44% | 16 |
6 | FAZALS MICROCOLONY COUNTING METHOD | authKW | 77741 | 0% | 100% | 4 |
7 | KRM 1648 | authKW | 77737 | 0% | 67% | 6 |
8 | KUZELL ARTHRITIS INFECT DIS | address | 69962 | 0% | 60% | 6 |
9 | MYCOBACTERIUM AVIUM INTRACELLULARE | authKW | 69078 | 1% | 22% | 16 |
10 | H2O2 MEDIATED HALOGENATION SYSTEM | authKW | 38870 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Infectious Diseases | 16761 | 31% | 0% | 486 |
2 | Microbiology | 14469 | 40% | 0% | 632 |
3 | Immunology | 7035 | 33% | 0% | 514 |
4 | Pharmacology & Pharmacy | 2375 | 24% | 0% | 382 |
5 | Respiratory System | 1984 | 10% | 0% | 153 |
6 | Medicine, General & Internal | 214 | 7% | 0% | 111 |
7 | Pathology | 192 | 4% | 0% | 60 |
8 | Virology | 61 | 2% | 0% | 32 |
9 | Ophthalmology | 53 | 2% | 0% | 35 |
10 | Tropical Medicine | 45 | 1% | 0% | 16 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MICROBIOL IMMUNOL INFECT | 140299 | 1% | 38% | 19 |
2 | KUZELL ARTHRIT INFECT DIS | 138188 | 1% | 44% | 16 |
3 | KUZELL ARTHRITIS INFECT DIS | 69962 | 0% | 60% | 6 |
4 | ABE SALAZAR BIOMED SCI | 19435 | 0% | 100% | 1 |
5 | ANTIVIRAL DRUG PROD HFD530 | 19435 | 0% | 100% | 1 |
6 | CIRCOLO MACCHI FDN | 19435 | 0% | 100% | 1 |
7 | CITOL EXPTL NACL INVEST CIENTIFICA | 19435 | 0% | 100% | 1 |
8 | CLIN 5P21 | 19435 | 0% | 100% | 1 |
9 | CLIN MYCOBACETERIOL SERV | 19435 | 0% | 100% | 1 |
10 | DIPARTIMENTO CHIM TECNOL SOSTANZE BIOLAGICAMENT | 19435 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TUBERCLE | 38642 | 2% | 7% | 30 |
2 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 26569 | 11% | 1% | 180 |
3 | TUBERCLE AND LUNG DISEASE | 17432 | 1% | 4% | 20 |
4 | AMERICAN REVIEW OF RESPIRATORY DISEASE | 6906 | 3% | 1% | 47 |
5 | JOURNAL OF INFECTIOUS DISEASES | 6793 | 5% | 0% | 79 |
6 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 5905 | 4% | 1% | 62 |
7 | INFECTION AND IMMUNITY | 5823 | 6% | 0% | 90 |
8 | RESEARCH IN MICROBIOLOGY | 4569 | 2% | 1% | 25 |
9 | FEMS MICROBIOLOGY IMMUNOLOGY | 3816 | 0% | 4% | 5 |
10 | CLINICAL INFECTIOUS DISEASES | 2737 | 3% | 0% | 43 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | STGEORGIEV, V , (1994) TREATMENT AND DEVELOPMENTAL THERAPEUTICS OF MYCOBACTERIUM-AVIUM COMPLEX (MAC) INFECTIONS.INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. VOL. 4. ISSUE 4. P. 247 -270 | 116 | 76% | 0 |
2 | BENSON, CA , ELLNER, JJ , (1993) MYCOBACTERIUM-AVIUM COMPLEX INFECTION AND AIDS - ADVANCES IN THEORY AND PRACTICE.CLINICAL INFECTIOUS DISEASES. VOL. 17. ISSUE 1. P. 7-20 | 68 | 83% | 164 |
3 | TARTAGLIONE, TA , (1996) THERAPEUTIC OPTIONS FOR THE MANAGEMENT AND PREVENTION OF MYCOBACTERIUM AVIUM COMPLEX INFECTION IN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME.PHARMACOTHERAPY. VOL. 16. ISSUE 2. P. 171-182 | 49 | 89% | 2 |
4 | BAKKER-WOUDENBERG, IAJM , VAN VIANEN, W , VAN SOOLINGEN, D , VERBRUGH, HA , VAN AGTMAEL, MA , (2005) ANTIMYCOBACTERIAL AGENTS DIFFER WITH RESPECT TO THEIR BACTERIOSTATIC VERSUS BACTERICIDAL ACTIVITIES IN RELATION TO TIME OF EXPOSURE, MYCOBACTERIAL GROWTH PHASE, AND THEIR USE IN COMBINATION.ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. VOL. 49. ISSUE 6. P. 2387-2398 | 37 | 84% | 16 |
5 | HORSBURGH, CR , (1991) CURRENT CONCEPTS - MYCOBACTERIUM-AVIUM COMPLEX INFECTION IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME.NEW ENGLAND JOURNAL OF MEDICINE. VOL. 324. ISSUE 19. P. 1332-1338 | 37 | 74% | 695 |
6 | BROGDEN, RN , FITTON, A , (1994) RIFABUTIN - A REVIEW OF ITS ANTIMICROBIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC EFFICACY.DRUGS. VOL. 47. ISSUE 6. P. 983-1009 | 58 | 68% | 86 |
7 | APPELBERG, R , (2006) PATHOGENESIS OF MYCOBACTERIUM AVIUM INFECTION - TYPICAL RESPONSES TO AN ATYPICAL MYCOBACTERIUM?.IMMUNOLOGIC RESEARCH. VOL. 35. ISSUE 3. P. 179-190 | 50 | 57% | 19 |
8 | HEIFETS, LB , (1996) CLARITHROMYCIN AGAINST MYCOBACTERIUM AVIUM COMPLEX INFECTIONS.TUBERCLE AND LUNG DISEASE. VOL. 77. ISSUE 1. P. 19-26 | 53 | 72% | 36 |
9 | GORDIN, FM , SULLAM, PM , SHAFRAN, SD , COHN, DL , WYNNE, B , PAXTON, L , PERRY, K , HORSBURGH, CR , (1999) A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF RIFABUTIN ADDED TO A REGIMEN OF CLARITHROMYCIN AND ETHAMBUTOL FOR TREATMENT OF DISSEMINATED INFECTION WITH MYCOBACTERIUM AVIUM COMPLEX.CLINICAL INFECTIOUS DISEASES. VOL. 28. ISSUE 5. P. 1080-1085 | 33 | 100% | 57 |
10 | GANGADHARAM, PRJ , REDDY, MV , (1994) CONTRIBUTIONS OF ANIMAL AND MACROPHAGE MODELS TO THE UNDERSTANDING OF HOST-PARASITE INTERACTION OF MYCOBACTERIUM-AVIUM COMPLEX (MAC) DISEASE.RESEARCH IN MICROBIOLOGY. VOL. 145. ISSUE 3. P. 214-224 | 50 | 82% | 6 |
Classes with closest relation at Level 1 |